Record NNP B-NP O
date NN I-NP O
: : O O
2083-12-15 CD O B-DATE
f/u NNS B-NP O
visit VBP B-VP O
for IN B-PP O
multiple JJ B-NP O
chronic JJ I-NP O
medical JJ I-NP O
probs NNS I-NP O
Problems NNS B-NP O
Congestive NNP B-NP O
heart NN I-NP O
failure NN I-NP O
Chronic NNP B-NP O
obstructive JJ I-NP O
pulmonary NN I-NP O
disease NN I-NP O
Hypertension NN B-NP O
Gout CC O O
DJD . O O
Benign NNP B-NP O
prostatic JJ I-NP O
hypertrophy NN I-NP O
Hyperlipidemia NNP B-NP O
Chronic NNP B-NP O
renal NNP I-NP O
dysfunction NN I-NP O
Peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
: : O O
s/p RB B-NP O
right JJ I-NP O
fem-tib NN I-NP O
bypass NN I-NP O
1/78 . O B-DATE
Prostatic JJ B-NP O
nodule NN I-NP O
: : O O
psa NN B-NP O
1.6 CD I-NP O
09/8 CD I-NP I-DATE
1 LS I-NP I-DATE
. . O O
seen VBN B-VP O
by IN B-PP O
dr NN B-NP O
. . O O
hoover NN B-NP B-DOCTOR
in IN B-PP O
11/8 CD B-NP I-DATE
1 CD I-NP I-DATE
who WP B-NP O
recommended VBD B-VP O
yearly RB I-VP O
follow VB I-VP O
up RP B-PRT O
. . O O
Coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
: : O O
ett NN B-NP O
exam NN I-NP O
: : O O
2080 CD B-NP B-DATE
The DT B-NP O
ECG JJ I-NP O
response NN I-NP O
to TO B-PP O
pharmacological JJ B-NP O
stress NN I-NP O
was VBD B-VP O
uninterpretable JJ B-ADJP O
for IN B-PP O
ischemia NN B-NP O
. . O O
The DT B-NP O
myocardial JJ I-NP O
perfusion NN I-NP O
images NNS I-NP O
reveal VBP B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-PP O
ischemia NN B-NP O
. . O O
The DT B-NP O
images NNS I-NP O
are VBP B-VP O
suggestive JJ B-ADJP O
of IN B-PP O
possible JJ B-NP O
prior JJ I-NP O
inferior JJ I-NP O
infarction NN I-NP O
although IN B-PP O
soft JJ B-NP O
tissue NN I-NP O
attenuation NN I-NP O
prevents VBZ B-VP O
a DT B-NP O
definitive JJ I-NP O
evaluation NN I-NP O
of IN B-PP O
this DT B-NP O
territory NN I-NP O
. . O O
sigmoid JJ B-NP O
colorectal JJ I-NP O
cancer NN I-NP O
: : O O
s/p NN B-NP O
sigmoid NN I-NP O
colectomy NN I-NP O
and CC I-NP O
sigmoidoscopy NN I-NP O
04/8 VBD B-VP I-DATE
2 CD O I-DATE
rs3PE . O O
Diabetes NNP B-NP O
mellitus NN I-NP O
Medications NNS B-NP O
Calcium NNP B-NP O
Carbonate NNP I-NP O
( -LRB- I-NP O
500 CD I-NP O
Mg NN I-NP O
Elemental JJ I-NP O
Ca MD B-VP O
) -RRB- I-VP O
500MG JJ B-ADJP O
, , O O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NNP I-NP O
QD NNP I-NP O
: : O O
Take VB B-VP O
as RB B-ADJP O
directed VBN I-ADJP O
Prilosec NNP B-NP O
( -LRB- I-NP O
OMEPRAZOLE NN I-NP O
) -RRB- I-NP O
20MG CD I-NP O
, , I-NP O
1 CD I-NP O
Capsule( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD . O O
Celebrex NNP B-NP O
( -LRB- I-NP O
CELECOXIB NN I-NP O
) -RRB- I-NP O
200MG CD I-NP O
, , I-NP O
1 CD I-NP O
Capsule( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NNP I-NP O
QD NNP I-NP O
: : O O
Take VB B-VP O
as RB B-ADJP O
directed VBN I-ADJP O
COLCHICINE NNP B-NP O
0.6MG NNP I-NP O
, , O O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NNP I-NP O
QOD NNP I-NP O
: : O O
Take VB B-VP O
as RB B-ADJP O
directed VBN I-ADJP O
Lopid NNP B-NP O
( -LRB- I-NP O
GEMFIBROZIL NNP I-NP O
) -RRB- B-VP O
600MG JJ B-ADJP O
, , O O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
BID . O O
DIGOXIN NNP B-NP O
0.125MG NNP I-NP O
, , O O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NNP I-NP O
QOD NNP I-NP O
: : O O
Take VB B-VP O
as RB B-ADJP O
directed VBN I-ADJP O
PREDNISONE JJ B-NP O
5MG JJ I-NP O
, , I-NP O
1 CD I-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD . O O
Coumadin NNP B-NP O
( -LRB- I-NP O
WARFARIN JJ I-NP O
Sodium NN I-NP O
) -RRB- I-NP O
3MG NN I-NP O
, , O O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NNP I-NP O
QPM NNP I-NP O
: : O O
Take VB B-VP O
as IN B-SBAR O
directed VBN B-VP O
per IN B-PP O
anticoag NN B-NP O
Isordil NNP B-NP O
( -LRB- I-NP O
ISOSORBIDE NN I-NP O
Dinitrate NN I-NP O
) -RRB- I-NP O
20MG CD I-NP O
, , I-NP O
1 CD I-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
TID NN I-NP O
: : O O
Take VB B-VP O
as RB B-ADJP O
directed VBN I-ADJP O
Kenalog NNP B-NP O
0.1 CD I-NP O
% NN I-NP O
( -LRB- I-NP O
TRIAMCINOLONE NNP I-NP O
Acetonide NNP I-NP O
0.1 CD I-NP O
% NN I-NP O
) -RRB- I-NP O
0.1 CD I-NP O
% NN I-NP O
, , O O
1 CD B-NP O
application NN I-NP O
TOP NNP I-NP O
BID NNP I-NP O
ALLOPURINOL NNP B-NP O
100MG NNP I-NP O
, , O O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NNP I-NP O
QD NNP I-NP O
: : O O
Take VB B-VP O
as RB B-ADJP O
directed VBN I-ADJP O
Hydralazine NNP B-NP O
Hcl NNP I-NP O
10MG NNP I-NP O
, , O O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NNP I-NP O
QID NNP I-NP O
x NN I-NP O
60 CD B-NP O
day( NN I-NP O
s VBZ B-VP O
) -RRB- B-ADJP O
: : O O
Take VB B-VP O
as RB B-ADJP O
directed VBN I-ADJP O
Lasix NNP B-NP O
( -LRB- I-NP O
FUROSEMIDE NNP I-NP O
) -RRB- B-VP O
40MG JJ B-ADJP O
, , O O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD . O O
Metoprolol NNP B-NP O
Tartrate NNP I-NP O
50MG NNP I-NP O
, , O O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
BID . O O
GLYBURIDE NNP B-NP O
1.25MG NNP I-NP O
, , O O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD . O O
CAD/ NNP B-NP O
HTN NNP I-NP O
no DT B-NP O
cp NN I-NP O
, , I-NP O
sob NNS I-NP O
or CC I-NP O
palpitations NNS I-NP O
no DT B-NP O
doe NN I-NP O
or CC I-NP O
nocturnal JJ I-NP O
sx NN I-NP O
knows VBZ B-VP O
not RB O O
to TO B-VP O
shovel VB I-VP O
snow NN B-NP O
overdue JJ B-ADJP O
for IN B-PP O
bp NN B-NP O
med NN I-NP O
which WDT B-NP O
he PRP B-NP O
will MD B-VP O
take VB I-VP O
when WRB B-ADVP O
he PRP B-NP O
gets VBZ B-VP O
home NN B-NP O
DM NNP B-NP O
brings VBZ B-VP O
in IN B-PP O
home NN B-NP O
record NN I-NP O
fbs NNS I-NP O
range VBP B-VP O
: : O O
116,115,107 CD B-NP O
, , I-NP O
117 CD I-NP O
, , I-NP O
98 CD I-NP O
, , I-NP O
99 CD I-NP O
, , I-NP O
136 CD I-NP O
4PM CD I-NP O
bs NNS I-NP O
151 CD I-NP O
, , I-NP O
146 CD I-NP O
, , I-NP O
155 CD I-NP O
, , I-NP O
144 CD I-NP O
, , I-NP O
145 CD I-NP O
, , I-NP O
114 CD I-NP O
, , I-NP O
211(ate JJ I-NP O
candy NN I-NP O
) -RRB- I-NP O
per IN B-PP O
son NN B-NP O
pt VBD B-VP O
still RB B-ADVP O
on IN B-PP O
half DT B-NP O
tab NN I-NP O
glucotrol NN I-NP O
until IN B-PP O
bottle NN B-NP O
finished VBD B-VP O
then RB B-ADVP O
will MD B-VP O
change VB I-VP O
to TO I-VP O
glyburide VB I-VP O
pt NN B-NP O
feels VBZ B-VP O
he PRP B-NP O
is VBZ B-VP O
eating VBG I-VP O
less RBR B-ADVP O
now RB I-ADVP O
no DT B-NP O
hypo NN I-NP O
sx NN I-NP O
prostate NN B-NP O
nodule NN B-VP O
no DT B-NP O
gu NN I-NP O
sx NN I-NP O
pvd NN B-NP O
denies VBZ B-VP O
leg NN B-NP O
pains NNS I-NP O
had VBD O O
nodules NNS B-NP O
L NNP I-NP O
arm NN I-NP O
excised VBN O O
concerned VBN B-NP O
re NN I-NP O
lump NN I-NP O
around IN B-PP O
navel FW B-NP O
occ FW I-NP O
tender NN I-NP O
denies VBZ B-VP O
pain NN B-NP O
no DT B-NP O
increase NN I-NP O
in IN B-PP O
size NN B-NP O
O UH B-NP O
: : O O
Vital JJ B-NP O
signs NNS I-NP O
BP NNP B-NP O
160/8 CD I-NP O
0 CD I-NP O
Right RB B-ADVP O
Arm NN B-VP O
,P RB B-NP O
72 CD I-NP O
Regular JJ I-NP O
,Wt NN I-NP O
183 CD B-NP O
lb NN I-NP O
chest NN B-NP O
clear JJ I-NP O
decreased VBN I-NP O
sounds NNS I-NP O
at IN B-PP O
base JJ B-NP O
cor JJ I-NP O
rr NNP I-NP O
at IN B-PP O
72 CD B-NP O
no DT B-NP O
m/g NN I-NP O
abdo NN B-NP O
sm NN I-NP O
ventral NN I-NP O
hernia CC O O
above IN B-SBAR O
umbilicus PRP B-NP O
reducible JJ B-NP O
nontender NN I-NP O
Labs NNP B-NP O
Psa NNP I-NP O
3 CD I-NP O
freepsa NN I-NP O
0.97 CD I-NP O
pct NN I-NP O
free JJ I-NP O
32.3 CD I-NP O
hgbA1c JJ B-NP O
6.4 CD I-NP O
( -LRB- I-NP O
127 CD I-NP O
) -RRB- O O
path NN B-NP O
report NN I-NP O
= SYM O O
palisading VBG B-VP O
granulomatous JJ B-NP O
tissue NN I-NP O
reaction NN I-NP O
A: NNP B-NP O
htn NN I-NP O
borderline NN I-NP O
? . O O
re VBD B-VP O
to TO B-PP O
med PRP B-NP O
overdue JJ O O
cad NN B-NP O
stable NN I-NP O
pvd NN B-NP O
stable NN I-NP O
dM JJ B-ADJP O
at IN B-PP O
goal NN B-NP O
to TO B-VP O
change VB I-VP O
to TO I-VP O
glyburide VB I-VP O
soon RB B-ADVP O
monitor VB B-VP O
bs NNS B-NP O
on IN B-PP O
new JJ B-NP O
meds NNS I-NP O
psa NN B-NP O
f/u NN I-NP O
Dr NNP I-NP O
Hoover . O B-DOCTOR
sm NN B-NP O
abdo NN I-NP O
hernia IN B-PP O
pt JJ B-NP O
ed JJ I-NP O
re NN I-NP O
prob NN I-NP O
monitor NN I-NP O
L NNP B-NP O
arm NN I-NP O
nodules NNS I-NP O
unclear JJ I-NP O
path NN I-NP O
dx NN I-NP O
rtc NN B-NP O
as IN B-PP O
sched VBN B-NP O
to TO B-PP O
Dr NNP B-NP O
Hale NNP I-NP B-DOCTOR
to TO B-PP O
me PRP B-NP O
April NNP B-NP B-DATE
call NN I-NP O
earlier RB B-ADVP O
prn . O O
Ottilie NNP B-NP B-DOCTOR
Kang NNP I-NP I-DOCTOR
,RNC,ANP . O O
